IBDEI03T ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1356,1,4,0)
 ;;=4^T45.1X5D
 ;;^UTILITY(U,$J,358.3,1356,2)
 ;;=^5051027
 ;;^UTILITY(U,$J,358.3,1357,0)
 ;;=T45.1X5S^^8^135^4
 ;;^UTILITY(U,$J,358.3,1357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1357,1,3,0)
 ;;=3^Adverse effect of antineopl and immunosup drugs, sequela
 ;;^UTILITY(U,$J,358.3,1357,1,4,0)
 ;;=4^T45.1X5S
 ;;^UTILITY(U,$J,358.3,1357,2)
 ;;=^5051028
 ;;^UTILITY(U,$J,358.3,1358,0)
 ;;=T36.8X5A^^8^135^7
 ;;^UTILITY(U,$J,358.3,1358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1358,1,3,0)
 ;;=3^Adverse effect of other systemic antibiotics, init encntr
 ;;^UTILITY(U,$J,358.3,1358,1,4,0)
 ;;=4^T36.8X5A
 ;;^UTILITY(U,$J,358.3,1358,2)
 ;;=^5049412
 ;;^UTILITY(U,$J,358.3,1359,0)
 ;;=T36.8X5D^^8^135^8
 ;;^UTILITY(U,$J,358.3,1359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1359,1,3,0)
 ;;=3^Adverse effect of other systemic antibiotics, subs encntr
 ;;^UTILITY(U,$J,358.3,1359,1,4,0)
 ;;=4^T36.8X5D
 ;;^UTILITY(U,$J,358.3,1359,2)
 ;;=^5049413
 ;;^UTILITY(U,$J,358.3,1360,0)
 ;;=T36.8X5S^^8^135^9
 ;;^UTILITY(U,$J,358.3,1360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1360,1,3,0)
 ;;=3^Adverse effect of other systemic antibiotics, sequela
 ;;^UTILITY(U,$J,358.3,1360,1,4,0)
 ;;=4^T36.8X5S
 ;;^UTILITY(U,$J,358.3,1360,2)
 ;;=^5049414
 ;;^UTILITY(U,$J,358.3,1361,0)
 ;;=T49.6X5A^^8^135^10
 ;;^UTILITY(U,$J,358.3,1361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1361,1,3,0)
 ;;=3^Adverse effect of otorhino drugs and preparations, init
 ;;^UTILITY(U,$J,358.3,1361,1,4,0)
 ;;=4^T49.6X5A
 ;;^UTILITY(U,$J,358.3,1361,2)
 ;;=^5051926
 ;;^UTILITY(U,$J,358.3,1362,0)
 ;;=T49.6X5D^^8^135^11
 ;;^UTILITY(U,$J,358.3,1362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1362,1,3,0)
 ;;=3^Adverse effect of otorhino drugs and preparations, subs
 ;;^UTILITY(U,$J,358.3,1362,1,4,0)
 ;;=4^T49.6X5D
 ;;^UTILITY(U,$J,358.3,1362,2)
 ;;=^5051927
 ;;^UTILITY(U,$J,358.3,1363,0)
 ;;=T49.6X5S^^8^135^12
 ;;^UTILITY(U,$J,358.3,1363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1363,1,3,0)
 ;;=3^Adverse effect of otorhino drugs and preparations, sequela
 ;;^UTILITY(U,$J,358.3,1363,1,4,0)
 ;;=4^T49.6X5S
 ;;^UTILITY(U,$J,358.3,1363,2)
 ;;=^5051928
 ;;^UTILITY(U,$J,358.3,1364,0)
 ;;=T36.95XA^^8^135^13
 ;;^UTILITY(U,$J,358.3,1364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1364,1,3,0)
 ;;=3^Adverse effect of unsp systemic antibiotic, init encntr
 ;;^UTILITY(U,$J,358.3,1364,1,4,0)
 ;;=4^T36.95XA
 ;;^UTILITY(U,$J,358.3,1364,2)
 ;;=^5049430
 ;;^UTILITY(U,$J,358.3,1365,0)
 ;;=T36.95XD^^8^135^14
 ;;^UTILITY(U,$J,358.3,1365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1365,1,3,0)
 ;;=3^Adverse effect of unsp systemic antibiotic, subs encntr
 ;;^UTILITY(U,$J,358.3,1365,1,4,0)
 ;;=4^T36.95XD
 ;;^UTILITY(U,$J,358.3,1365,2)
 ;;=^5049431
 ;;^UTILITY(U,$J,358.3,1366,0)
 ;;=T36.95XS^^8^135^15
 ;;^UTILITY(U,$J,358.3,1366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1366,1,3,0)
 ;;=3^Adverse effect of unspecified systemic antibiotic, sequela
 ;;^UTILITY(U,$J,358.3,1366,1,4,0)
 ;;=4^T36.95XS
 ;;^UTILITY(U,$J,358.3,1366,2)
 ;;=^5049432
 ;;^UTILITY(U,$J,358.3,1367,0)
 ;;=S04.60XA^^8^135^16
 ;;^UTILITY(U,$J,358.3,1367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1367,1,3,0)
 ;;=3^Injury of acoustic nerve, unspecified side, init encntr
 ;;^UTILITY(U,$J,358.3,1367,1,4,0)
 ;;=4^S04.60XA
 ;;^UTILITY(U,$J,358.3,1367,2)
 ;;=^5020537
 ;;^UTILITY(U,$J,358.3,1368,0)
 ;;=S04.9XXA^^8^135^17
 ;;^UTILITY(U,$J,358.3,1368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1368,1,3,0)
 ;;=3^Injury of unspecified cranial nerve, initial encounter
 ;;^UTILITY(U,$J,358.3,1368,1,4,0)
 ;;=4^S04.9XXA
